Publications by authors named "Lisa Adler"

Claim this Profile
M
Mirtazapine Is Associated With Shorter Hospital Stay in Pediatric Avoidant Restrictive Food Intake Disorder-A Retrospective Chart Review.
Aman Chishti, Rachael E Groh, Tamara R Maginot, Lisa Adler, Megan E Shott

Int J Eat Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taste assessment for paediatric drug Development: A comparison of bitterness taste aversion in children versus Naïve and expert young adult assessors.
Sejal R Ranmal, Zeineb Nhouchi, Alexander Keeley, Lisa Adler, Marc Lavarde

Int J Pharm· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
I know I am not out of control, but I just cannot shake the feeling: exploring feeling out of control in eating disorders.
Lisa Adler, Tiffany A Brown, Megan E Shott, Skylar Swindle, Guido K W Frank

Eat Weight Disord· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.
Gini F Fleming, Michael W Sill, Kathleen M Darcy, D Scott McMeekin, J Tate Thigpen, Lisa M Adler

Gynecol Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of medication adherence in children and adults with ADHD.
Lisa D Adler, Andrew A Nierenberg

Postgrad Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): a Gynecologic Oncology Group Study.
Paul Sabbatini, Michael W Sill, David O'Malley, Lisa Adler, Angeles Alvarez Secord

Gynecol Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.
Paula M Fracasso, John A Blessing, Kelly L Molpus, Lisa M Adler, Joel I Sorosky

Gynecol Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis